within Pharmacolibrary.Drugs.ATC.S;

model S01AD09
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 3.5 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 5 / 1000000,
    adminCount     = 1,
    Vd             = 0.0007,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Ganciclovir is an antiviral medication used mainly to treat cytomegalovirus (CMV) infections, particularly in immunocompromised patients such as those with AIDS or organ transplant recipients. It is approved and used today for the treatment and prevention of CMV infections.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in adult subjects following intravenous administration; general population including immunocompromised patients.</p><h4>References</h4><ol><li><p>Corum, O, et al., &amp; Elmas, M (2022). Effect of ketoprofen on intravenous pharmacokinetics of ganciclovir in chukar partridges (Alectoris chukar). <i>Journal of veterinary pharmacology and therapeutics</i> 45(1) 126–132. DOI:<a href=&quot;https://doi.org/10.1111/jvp.13027&quot;>10.1111/jvp.13027</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34719792/&quot;>https://pubmed.ncbi.nlm.nih.gov/34719792</a></p></li><li><p>Nguyen, T, et al., &amp; Hirt, D (2021). Population Pharmacokinetics of Intravenous Ganciclovir and Oral Valganciclovir in a Pediatric Population To Optimize Dosing Regimens. <i>Antimicrobial agents and chemotherapy</i> 65(3) –. DOI:<a href=&quot;https://doi.org/10.1128/AAC.02254-20&quot;>10.1128/AAC.02254-20</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33318012/&quot;>https://pubmed.ncbi.nlm.nih.gov/33318012</a></p></li><li><p>Okumura, N, et al., &amp; Koizumi, N (2019). Stability, safety, and pharmacokinetics of ganciclovir eye drops prepared from ganciclovir for intravenous infusion. <i>Japanese journal of ophthalmology</i> 63(3) 289–296. DOI:<a href=&quot;https://doi.org/10.1007/s10384-019-00665-8&quot;>10.1007/s10384-019-00665-8</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30941593/&quot;>https://pubmed.ncbi.nlm.nih.gov/30941593</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end S01AD09;
